Prescription Drug Price Reporting Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Nov 21, 2019)
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
What just happenedNov 22, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseNov 21, 2019
- Nov 22, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Nov 21, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Nov 21, 2019IntroReferralIntro-H
Introduced in House
- Nov 21, 2019IntroReferral1000
Introduced in House